US 2012/0088742 A1 · ACETYLSALICYLIC ACID SALTS

Abstract

Novel betaine salts of acetylsalicylic acid, namely 4-trimethylammoniobutanoate acetylsalicylic acid addition salt (gamma-butyrobetaine acetylsalicylate), L-carnitine acetylsalicylic acid addition salt and 3-(trimethylammonioamino)propanoate (meldonium) acetylsalicylic acid addition salt. Use of meldonium acetylsalicylate as antiplatelet agent for treating various pathologies induced by platelet aggregation, anti-inflammatory and antihyperlipidemic agent.

Claims26

Dependent claims

1-26. (canceled)

Dependencies are inferred from the claim text.

Facts

Application

13/377,926Filed 21 Jun 2010

Published

12 Apr 2012

Term ends

Not estimatedThe source records don’t support an estimate.

Classification15 codes

C07C 229/12
The nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic…
A61K 31/616
Having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid: by carboxylic acids, e.g. acetylsalicylic acid
A61P 3/06
Drugs for disorders of the metabolism: antihyperlipidemics
A61P 7/02
Drugs for disorders of the blood or the extracellular fluid: antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Abstract

Claims26

Dependent claims

1-26. (canceled)

Dependencies are inferred from the claim text.

Acetylsalicylic acid salts

Life of this patent

Abstract

Claims26

Acetylsalicylic acid salts

Life of this patent

Abstract

Claims26